Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty
Clinical trial NCT03429556 · TERMINATED
Trial details
- NCT number
- NCT03429556
- Sponsor
- Allergan
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-08
- Primary completion
- 2018-07-10
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.